Aimed Bio Inc. (KOSDAQ:0009K0)

Aimed Bio Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	30,174	106,408	4,488	1,463	2,872
Short-Term Investments	54,000	64,420	31,030	16,618	3,146
Cash & Short-Term Investments	92,666	170,828	35,519	18,081	6,018
Cash Growth	5.11%	380.96%	96.45%	200.42%	-
Accounts Receivable	15,169	3,300	-	-	45.46
Other Receivables	1,560	2,871	459.85	659.65	388.9
Receivables	16,728	6,171	459.85	659.65	434.36
Prepaid Expenses	-	-	103.96	-	-
Other Current Assets	4,579	1,523	144.95	68.76	130.83
Total Current Assets	113,973	178,523	36,227	18,809	6,584
Property, Plant & Equipment	3,302	2,104	1,469	2,353	2,157
Long-Term Investments	75,908	1,835	6,537	220.88	1,305
Other Intangible Assets	1,498	1,619	1,742	334.61	325.41
Long-Term Deferred Tax Assets	15,901	13,683	-	-	-
Other Long-Term Assets	1,397	1,205	1,166	714.93	558.24
Total Assets	211,978	198,969	47,141	22,432	10,929

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Accrued Expenses	649.28	910.67	181.93	197.61	63.69
Current Portion of Leases	940.59	639.58	425.57	525.67	490.95
Current Unearned Revenue	113.64	340.91	795.46	1,295	140.79
Other Current Liabilities	4,873	3,788	725.35	2,404	227.48
Total Current Liabilities	6,577	5,679	2,128	4,423	922.9
Long-Term Leases	630.93	525.13	-	375.01	521.93
Other Long-Term Liabilities	318.25	192.23	195.6	32.43	28.98
Total Liabilities	7,526	6,397	2,324	4,830	1,474

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Common Stock	32,336	32,078	17,735	17,735	16,716
Additional Paid-In Capital	181,534	179,636	8,979	8,979	4,830
Retained Earnings	-12,540	-21,413	-26,436	-23,132	-14,109
Comprehensive Income & Other	3,121	2,268	3,082	3,112	2,007
Total Common Equity	204,450	192,569	3,360	6,694	9,443
Minority Interest	2.39	3.15	7.5	15.66	12.29
Shareholders' Equity	204,453	192,572	44,817	17,602	9,456
Total Liabilities & Equity	211,978	198,969	47,141	22,432	10,929

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Total Debt	1,572	1,165	425.57	900.68	1,013
Net Cash (Debt)	91,094	169,663	35,093	17,180	5,006
Net Cash Growth	3.53%	383.47%	104.27%	243.21%	-
Net Cash Per Share	1389.47	3419.42	987.82	503.02	149.73
Filing Date Shares Outstanding	64.78	64.16	35.47	35.47	33.43
Total Common Shares Outstanding	64.78	64.16	35.47	35.47	33.43
Working Capital	107,396	172,843	34,099	14,386	5,661
Book Value Per Share	3155.87	3001.56	94.73	188.73	282.47
Tangible Book Value	202,953	190,950	1,619	6,360	9,118
Tangible Book Value Per Share	3132.75	2976.32	45.63	179.29	272.73
Machinery	3,231	2,712	2,469	2,329	1,895

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error